Muhammad Afzal, Zubia Hassan, Saad Afzal, Rimsha Azhar, Huzaifa Quershi, Samra Hassan
ABSTRACT
Objective: To identify the association of serum albumin levels with the severity of illness in patients diagnosed with dengue fever
Study Design: Cross-sectional study.
Place and Duration of Study: The Study was conducted at the Medicine Department of Margalla Institute of Health Sciences Islamabad, Pakistan from July 2022 to June, 2023.
Methods: A total of 82 diagnosed cases of dengue fever were included in the study. All the baseline investigations were done including serum albumin at the time of diagnosis. The severity of the illness was determined on the basis of platelet counts during the first week of illness. The association of various socio-demographic factors including albumin levels was determined with the severity of illness in the study participants.
Results: The mean age of study participants was 32.6±8.71years with 56 (68.3%) were males and 26 (31.7%) were females. Out of 82 dengue fever patients, 61 (74.4%) had mild illness while 21 (25.6%) had severe form of dengue fever. 53 (64.6%) had normal albumin levels while 29 (35.4%) had deranged albumin levels. Pearson chi-square analysis revealed that deranged albumin levels and wide pulse pressure had statistically significant relationship with presence of severe dengue fever in our study participants (P-value<0.001).
Conclusion: Patients with deranged albumin levels and wide pulse pressure during the course of illness were more at risk of having severe dengue fever.
Keywords: Albumin, Association, Dengue Fever.
How to cite this: Afzal M, Hassan Z, Afzal S, Azhar R, Quershi H, Hassan S. Association of Serum Albumin Levels with Severity of Illness in Patients with Dengue Fever at Margalla Institute of Health Sciences, Islamabad. Life and Science. 2024; 5(3): 350-354. doi: http://doi.org/10.37185/LnS.1.1.495
Read PDFLife and Science is recognized by Pakistan Medical and Dental Council (PM&DC), Islamabad, Pakistan
All the articles published in Life and Science are licensed under a
Creative Commons Attribution-NonCommercial 4.0 International License